CELH vs CROX: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: CROX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CELH and CROX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CELH and CROX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Celsius Holdings is a Boca Raton, Florida consumer packaged goods company that makes functional energy drinks marketed around fitness, metabolism, and zero-sugar formulations. Its flagship CELSIUS brand is sold through grocery, club, convenience, and fitness channels, and the company makes money by selling cases of ready-to-drink beverages, increasingly through PepsiCo's distribution network. In Q2 2026 the broader portfolio held roughly a 20.1% dollar share of the U.S. ready-to-drink energy category (down from about 20.9% in Q1), placing it behind Monster and Red Bull but well ahead of most other challengers.

Full CELH guide

Crocs, Inc. designs and sells casual footwear under two brands. The Crocs Brand centers on its signature molded clog made from a proprietary closed-cell resin the company calls Croslite, extended through sandals, sneakers, and the Jibbitz charms that let buyers personalize their shoes. In 2022 Crocs acquired HEYDUDE, a lightweight casual-shoe brand, to add a second growth engine. The company sells through wholesale partners and a growing direct-to-consumer channel that includes its own websites and stores, and it markets heavily through collaborations and celebrity tie-ins. Crocs is known for operating margins well above most footwear peers (about 24% on a trailing basis, with gross margin near 57%), driven by a simple core product, strong pricing, and relatively low marketing spend versus sales.

Full CROX guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CELH drivers: Multi-brand portfolio and category leadership; PepsiCo distribution and the category-captain role.
• CROX drivers: High-margin core Crocs Brand; Cash generation and share buybacks.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The flagship CELSIUS brand slowed to roughly 6% growth in Q1 2026 and then shrank about 11.7% year over year in Q2 2026, so the portfolio's growth now rests on Alani Nu and Rockstar, and total revenue growth fell to about 10.6% once those brands entered the prior-year base. For CROX, the largest risk is that Crocs depends heavily on one iconic product, so a shift in fashion or a fading of the clog trend could hurt demand quickly, and single-product concentration makes the stock sensitive to sentiment about the brand's staying power.

Pick CELH if you believe its drivers more; CROX if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CELH and CROX guides.

CELH. Reported figures are drawn from Celsius Holdings' Q2 2026 results and market data as of October 16, 2026. Trailing GAAP earnings are depressed by acquisition-related charges, so the trailing P/E near 125 times says little; on forward estimates the stock trades near 17 times earnings and about 2.4 times sales. Shares near $29 sit about 40% below where they started 2026 and well below the 52-week high of $66, a valuation that now reflects doubts about the core brand rather than the growth premium it once carried.

CROX. Even after a roughly 44% gain in 2026, Crocs trades near 11 times trailing and 8 times forward earnings, cheap for a business with mid-20s operating margins, because the market still questions how long single-product profitability lasts and how much HEYDUDE will cost. Analysts' mean target is about $138.75 across 12 covering firms. The October 29, 2026 Q3 report (consensus ~$1.0 billion revenue, $3.30 EPS) will show whether the second-quarter return to growth holds.

Headline figures (approximate, October 2026): CELH shows revenue (ttm) ~$3.05 billion, revenue (q2 2026) ~$817.9 million, up ~10.6% YoY, celsius brand revenue (q2 2026) Down ~11.7% YoY, gross margin (q2 2026) ~48.1% (down ~340 bps); CROX shows revenue (ttm) ~$4.05 billion; Q2 2026 ~$1.18 billion, up ~2.6% year over year, margins (ttm) Gross ~57%, operating ~24%, net ~15%, net income / eps (ttm) ~$593 million; trailing EPS ~$11.41, p/e (trailing / forward) ~10.9x / ~8.3x.

CELH and CROX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CELH and CROX exposure against your real portfolio. It is not an investment adviser.